Codar GF and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Codar GF and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: codeine / guaifenesin
Brand name: Allfen CD, Cheracol with Codeine, Cheratussin AC, Codar GF, Duraganidin NR, Guaiatussin AC, Iophen-C NR, Mar-cof CG, M-Clear, Mytussin AC, Relcof C, Guaifenesin AC Liquid, Iophen C-NR, Mar-cof CG, Ninjacof-XG, Virtussin A/C
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Codar GF-Insulin glargine, recombinant Subcutaneous
- Codar GF-Insulin glulisine
- Codar GF-Insulin Glulisine (Cartridges and Pens)
- Codar GF-Insulin Glulisine (Vials)
- Codar GF-Insulin glulisine Subcutaneous
- Codar GF-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Codeine
- Insulin glargine and lixisenatide Subcutaneous-Codeine and Chlorpheniramine
- Insulin glargine and lixisenatide Subcutaneous-Codeine and Chlorpheniramine ER Tablets
- Insulin glargine and lixisenatide Subcutaneous-Codeine and Chlorpheniramine Extended-Release Suspension
- Insulin glargine and lixisenatide Subcutaneous-Codeine and Chlorpheniramine Extended-Release Tablets
- Insulin glargine and lixisenatide Subcutaneous-Codeine and Chlorpheniramine Liquid